Hepatitis B 145 positive usually means that the hepatitis B surface antigen, hepatitis B E antibody and hepatitis B core antibody are positive, indicating that the patient is infected by the hepatitis B virus and is a hepatitis B virus carrier. Hepatitis B 145 positivity is often referred to as minor triple positive and requires further testing for hepatitis B virus DNA and liver function. It is usually believed that the number of viruses in the body of patients with hepatitis B minor triple positive is relatively small, the ability of viral replication is low, and the contagiousness is weak. If the examination of liver function is normal, generally no special treatment is needed, and regular review can be done. If the hepatitis B minor triple positive test shows that the hepatitis B virus DNA is positive and liver function is abnormal, then it indicates that it is chronic hepatitis B. If it is not actively treated, it will easily lead to hepatitis B. If not actively treated, it will easily lead to the deterioration of the disease, accelerate the development of liver fibrosis and cirrhosis, and induce a variety of complications, thus endangering life. Patients need to be actively treated. Common treatments include antiviral therapy and liver protection therapy, and you can choose antiviral drugs such as entecavir dispersible tablets and liver-protecting drugs such as reduced glutathione tablets under the guidance of your doctor. Once diagnosed with Hepatitis B 145 positive, patients are advised to have a physical examination in time and actively cooperate with the treatment. Drugs should be used under the guidance of a professional physician, and should not be used arbitrarily.